Most Popular Angioplasty Web Site
supported by Volcano Corporation
Volcano Corporation Announces North America Resale Agreement with Royal Philips Electronics

external sites:
Volcano Corporation

March 31, 2008 -- San Diego
-- Volcano Corporation (Nasdaq: VOLC), leading manufacturer of intravascular ultrasound (IVUS), announced today that it has entered into a non-exclusive, resale agreement covering North America with Royal Philips Electronics. Under this agreement, Philips will resell Volcano-branded s5i IVUS systems and accessories alongside of the Philips Allura Xper FD X-ray systems.

The Volcano s5i intravascular ultrasound (IVUS) system is compatible with Philips Allura Xper FD and is installed in conjunction with the X-ray system.

Volcano's s5i is a component-based IVUS system which is incorporated directly into the cath lab, allowing IVUS to be always on and always ready.

Angiogram compared to IVUS
top: Standard angiogram of stented artery
bottom: IVUS showing stent struts in need of further expansion

As a technology leader in the cath lab market, Philips strives to offer the most complete, state-of- the-art cath lab -- while retaining optimal work-flows. Volcano's s5i IVUS system is uniquely suited to meet those needs, as it interacts seamlessly with the Philips x-ray systems.

Physicians are recognizing the value of IVUS as an integral part of daily percutaneous coronary interventions.

Volcano's imaging technology gives clinicians the ability to visualize vessel geometry, understand plaque composition and make measurements for stent sizing.

"As IVUS usage is growing worldwide, it is increasingly common for customers to include IVUS technology in their cath lab design from the very beginning," commented Scott Huennekens, president and chief executive officer of Volcano. "Our agreement with Philips is yet another example of Volcano's commitment to provide customers with market leading IVUS technology that functions seamlessly with their X-ray equipment."

Volcano Corporation is pleased that this resale agreement builds upon the established compatibility between the Philips Allura Xper FD systems and the Volcano s5i integrated IVUS system which was demonstrated at the American College of Cardiology (ACC) summit in March 2007. Additionally, in September 2007 Philips Electronics Japan and Volcano Japan entered into a marketing alliance to promote Volcano's s5i IVUS system with Philips cardiovascular x-ray equipment in Japan.

About Volcano Corporation
Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH™ IVUS tissue characterization and ChromaFlo®. Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires. Currently, more than 3,200 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this news release regarding Volcano's business that are not historical facts may be considered "forward-looking statements," including statements regarding the resale of our systems and accessories by Philips and the safety and efficacy of the company's products. Forward-looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties, which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from the results predicted are detailed in the company's annual report on Form 10-K, future quarterly reports on Form 10-Q and other filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events.

Source: Volcano Corporation